// App-Quantinova.ai

TCT-429 : Short- and intermediate- term clinical outcomes after implantation of everolimus-eluting bioresorbable scaffold in complex lesions : a prospective single-arm study - ABSORB Expand trial

Researchers

Presenter

  • Robert J. Van Geuns

Principal Investigators

  • Peter De Jaegere

  • Roberto Diletti

  • Antonios Karanasos

  • Takashi Muramatsu

  • Sjoerd T. Nauta

  • Yoshinobu Onuma

  • Evelyn Regar

  • Carl J. Schultz

  • Patrick W. Serruys

Medical Centers

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • Thoraxcenter, Rotterdam, The Netherlands, Rotterdam, Netherlands

  • Erasmus MC, Rotterdam, Netherlands

  • Thoraxcenter, Rotterdam, Netherlands

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic total occlusion

  • Myocardial infarction

  • Angina

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved